ArticleFrontiers in immunology2026
Reduced IgM natural autoantibody levels against heat shock proteins are associated with disease severity in juvenile idiopathic arthritis.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Natural autoantibodies (nAAbs) contribute to immune homeostasis and may be altered in patients with autoimmune diseases. While anti-heat shock protein (Hsp) antibodies have been previously described in juvenile idiopathic arthritis (JIA), their relationship with disease severity and treatment effects during remission remains unclear. This study aimed to measure the serum levels of IgM and IgG nAbs against heat shock protein (Hsp) 60 and Hsp70 in children with JIA in remission (mean age: 7.41 years, range:1.27-14.54 years) and to explore their associations with disease subtype, severity, and treatment. Methods: Serum samples from 47 children with JIA in remission and 22 apparently healthy controls (HC) were analyzed. Patient groups were stratified according to the treatment regimen (methotrexate monotherapy versus methotrexate plus adalimumab) and disease subtype and severity. Anti-Hsp60 and anti-Hsp70 IgM and IgG antibodies were measured u Results: No significant differences in anti-Hsp60 or anti-Hsp70 nAAb levels were observed between patients with JIA and apparently healthy controls or between treatment groups. However, severity-based analyses revealed significantly lower anti-Hsp60 and anti-Hsp70 IgM levels in patients with polyarticular JIA than in those with milder oligoarticular forms and in apparently healthy controls. No significant differences were observed in the anti-Hsp60 or anti-Hsp70 IgG levels. Conclusion: Reduced levels of natural IgM autoantibodies against Hsp60 and Hsp70 are associated with more severe JIA phenotypes during remission, supporting the potential immunoregulatory and protective roles of natural IgM autoantibodies in JIA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.